Smoothelin is a cytoskeletal protein specifically expressed in differentiated smooth muscle cells and has been shown to colocalize with smooth muscle alpha actin. In addition to the small smoothelin isoform of 59 kD, we recently identified a large smoothelin isoform of 117 kD. The aim of this study was to identify and characterize novel smoothelin isoforms. The genomic structure and sequence of the smoothelin gene were determined by genomic PCR, RT-PCR and DNA sequencing. Comparison of the cDNA and genomic sequences shows that the small smoothelin isoform is generated by transcription initiation 10 kb downstream of the start site of the large isoform. In addition to the known smoothelin cDNA (c1 isoform) we identified two novel cDNA variants (c2 and c3 isoform) that are generated by alternative splicing within a region, which shows similarity to the spectrin family of F-actin cross-linking proteins. Visceral organs express the c1 form, while the c2 form prevails in well-vascularized tissue as analyzed by RT-PCR. We then generated specific antibodies against the major smoothelin isoforms and could show by Western blotting and immunohistochemistry that the large isoform is specifically expressed in vascular smooth muscle cells, while the small isoform is abundant in visceral smooth muscle. These results strongly suggest that the smoothelin gene contains a vascular and a visceral smooth muscle promoter. The cell-type-specific expression of smoothelin isoforms that are associated with actin filaments may play a role in the modulation of the contractile properties of different smooth muscle cell types.

Keywords:
Smoothelin, Arteries, Developmental biology, Smooth muscle, Cytoskeleton
1.
Duband JL, Gimona M, Scatena M, Sartore S, Small JV: Calponin and SM 22 as differentiation markers of smooth muscle: Spatiotemporal distribution during avian embryonic development. Differentiation 1993;55:1–11.
2.
Campbell JH, Kocher O, Skalli O, Gabbiani G, Campbell GR: Cytodifferentiation and expression of alpha-smooth muscle actin mRNA and protein during primary culture of aortic smooth muscle cells. Correlation with cell density and proliferative state. Arteriosclerosis 1989;9:633–643.
3.
Frid MG, Shekhonin BV, Koteliansky VE, Glukhova MA: Phenotypic changes of human smooth muscle cells during development: Late expression of heavy caldesmon and calponin. Dev Biol 1992;153:185–193.
4.
Henderson JR, Macalma T, Brown D, Richardson JA, Olson EN, Beckerle MC: The LIM protein, CRP1, is a smooth muscle marker. Dev Dyn 1999;214:229–238.
5.
Li L, Miano JM, Mercer B, Olson EN: Expression of the SM22alpha promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cellss. J Cell Biol 1996;132:849–859.
6.
Hungerford JE, Owens GK, Argraves WS, Little CD: Development of the aortic vessel wall as defined by vascular smooth muscle and extracellular matrix markers. Dev Biol 1996;178:375–392.
7.
Sobue K, Hayashi K, Nishida W: Expressional regulation of smooth muscle cells-specific genes in association with phenotypic modulation. Mol Cell Biochem 1999;190:105–118.
8.
Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993;362:801–809.
9.
Topouzis S, Majesky MW: Smooth muscle lineage diversity in the chick embryo. Two types of aortic smooth muscle cell differ in growth and receptor-mediated transcriptional responses to transforming growth factor-beta. Dev Biol 1996;178:430–445.
10.
Dettman RW, Denetclaw W Jr, Ordahl CP, Bristow J: Common epicardial origin of coronary vascular smooth muscle, perivascular fibroblasts, and intermyocardial fibroblasts in the avian heart. Dev Biol 1998;193:169–181.
11.
Gittenberger-De Groot AC, Deruiter MC, Bergwerff M, Poelmann RE: Smooth muscle cell origin and its relation to heterogeneity in development and disease. Arterioscler Thromb Vasc Biol 1999;19:1589–1594.
12.
Arner A, Malmqvist U: Cross-bridge cycling in smooth muscle: A short review. Acta Physiol Scand 1998;164:363–372.
13.
Stull JT, Lin PJ, Krueger JK, Trewhella J, Zhi G: Myosin light chain kinase: Functional domains and structural motifs. Acta Physiol Scand 1998;164:471–482.
14.
Van Der Loop FT, Schaart G, Timmer ED, Ramaekers FC, Van Eys GJ: Smoothelin, a novel cytoskeletal protein specific for smooth muscle cells. J Cell Biol 1996;134:401–411.
15.
Christen T, Bochaton-Piallat ML, Neuville P, Rensen S, Redard M, Van Eys G, Gabbiani G: Cultured porcine coronary artery smooth muscle cells. A new model with advanced differentiation. Circ Res 1999;85:99–107.
16.
Van Eys GJ, Voller MC, Timmer ED, Wehrens XH, Small JV, Schalken JA, Ramaekers FC, Van Der Loop FT: Smoothelin expression characteristics: Development of a smooth muscle cell in vitro system and identification of a vascular variant. Cell Struct Funct 1997;22:65–72.
17.
Krämer J, Aguirre-Arteta AM, Thiel C, Gross CM, Dietz R, Cardoso MC, Leonhardt H: A novel isoform of the smooth muscle cell differentiation marker smoothelin. J Mol Med 1999;77:294–298.
18.
Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ: Basic local alignment search tool. J Mol Biol 1990;215:403–410.
19.
Rensen S, Merkx G, Doevendans P, Geurts Van Kessel A, Van Eys G: Structure and chromosome location of Smtn, the mouse smoothelin gene. Cytogenet Cell Genet 2000;89:225–229.
20.
Senapathy P, Shapiro MB, Harris NL: Splice junctions, branch point sites, and exons: Sequence statistics, identification, and applications to genome project. Methods Enzymol 1990;183:252–278.
21.
Keep NH, Norwood FI, Moores CA, Winder SJ, Kendrick-Jones J: The 2.0 A structure of the second calponin homology domain from the actin-binding region of the dystrophin homologue utrophin. J Mol Biol 1999;285:1257–1264.
22.
Wehrens XH, Mies B, Gimona M, Ramaekers FC, Van Eys GJ, Small JV: Localization of smoothelin in avian smooth muscle and identification of a vascular-specific isoform. FEBS Lett 1997;405:315–320.
23.
Johansson B, Eriksson A, Ramaekers F, Thornell L: Smoothelin in adult and developing human arteries and myocardium. Histochem Cell Biol 1999;112:291–299.
24.
Gsell S, Eschenhagen T, Kaspareit G, Nose M, Scholz H, Behrens O, Wieland T: Apparent up-regulation of stimulatory G-protein alpha subunits in the pregnant human myometrium is mimicked by elevated smoothelin expression. FASEB J 2000;14:17–26.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.